Vaccination of Rhesus monkeys (Macaca mulatta) against Plasmodium knowlesi by the use of nonviable antigen.
- 1 May 1973
- journal article
- Vol. 48 (5) , 597-604
Abstract
This study was part of a long-term project with the ultimate goal of developing a malaria vaccine for use in man. Rhesus monkeys that had been vaccinated with a nonviable antigen given in combination with Freund's adjuvant were protected against a normally lethal challenge of Plasmodium knowlesi. Use of the antigen alone or in combination with other adjuvants was not successful. The fact that monkeys were protected against an infection that is normally lethal suggests that a similarly prepared antigen might be of use against malaria in human beings.This publication has 11 references indexed in Scilit:
- Plasmodium: A resumé of the isolation of a vaccine fraction by the French pressure cell techniqueExperimental Parasitology, 1972
- Suppression of Tumor Growth at the Site of Infection With Living Bacillus Calmette-GuérinJNCI Journal of the National Cancer Institute, 1971
- Isolation of immunological adjuvant component from B.C.G. cells.1971
- Immunity to malariaExperimental Parasitology, 1970
- Immunological Factors in Human Sarcomas and MelanomasAnnals of Surgery, 1970
- Malaria Resistance: Artificial Induction with a Partially Purified Plasmodial FractionScience, 1970
- Isolated Erythrocytic Forms of Plasmodium BergheiThe American Journal of Tropical Medicine and Hygiene, 1969
- Immunization of rhesus monkeys against Plasmodium knowlesi malariaExperimental Parasitology, 1965
- Immunization of Rhesus Monkeys against Malarial Infection ( P. knowlesi ) with Killed Parasites and AdjuvantsScience, 1945
- PRODUCTION IN MONKEYS OF COMPLEMENT-FIXING ANTIBODIES WITHOUT ACTIVE IMMUNITY BY INJECTION OF KILLED PLASMODIUM KNOWLESIThe Journal of Experimental Medicine, 1939